Dips Don't Last: 5 Stocks To Buy Now

Market dips don't last forever. So, right now, we're four years into a strong bull market. When the market pulls back like now, then even the best companies get dragged down right alongside the junk. Here's the big difference. The junk stays down while the quality stocks bounce back with gusto. Right? So, today I'm walking through five juicy buy the dip opportunities. Each one with a growth story staying intact even as the price recently faltered. And each one came straight out of our market beating quant. Note that I'm saving the biggest bargain of the bunch for last. So, be sure to stick around all the way to the end. Now, we'll get the party started with a quietly excellent materials company in Avon with a symbol of AV NT. Now, the company makes the specialized plastics, colorants, and additives that go into everything from packaging to medical devices to defense gear. Unglamorous, but absolutely essential and absolutely everywhere. Now, before we get too far along in the Avant story, I should probably tell you who I am. I'm Steve Wrightmeister, but everyone calls me Riley. I'm a partner at Wall Street Zen, where our quant rating system evaluates stocks across 115 different fundamental, technical, and AI factors to find the absolute best opportunities. All right. And if you like stockpicking videos like this one, then do your future self a solid and hit that like button. It tells the algorithm to send you more videos like this in the future. All right. The reason Aviant made the list today is because shares have faltered 15% from the highs. All the while, the business keeps executing, right? Earnings are expected to grow about 20%. The reason Aviant made the list today is because shares have faltered 15% from the highs. All the while the business continues to execute, right? For example, in the most recent quarterly report, earnings grew 20% year-over-year. This is becoming a healthy habit as they have topped estimates for five quarters in a row. That consistently usually pretends even more beats ahead. Now, on top of that, it's a downright bargain. Avon trades at a PEG ratio of just 0.62. Now, as you probably know, the PEG ratio stands for the price to earnings growth ratio, which tells you about how much you're paying for each percentage of point of growth. These days, the average stock trades for about a peg of 1.5. Thus, in that light, it's clear how dirt cheap Avon is at only 0.62. In this case, Wall Street coverage is pretty thin. Gladly, both analysts on board are firmly in the strong buy camp, each pointing to ample upside ahead for shares. Now, in my book, thin coverage is often a bonus, especially if those earnings beats continue. That's because new analysts will see that and get on board with new buy recommendations, helping to bush shares, all to the benefit of us early movers. Now, let's pop the hood with our Zen range quant. Now, here's how it works. Again, we analyze every stock across 115 different fundamental, technical, and AI factors, then boil it all down to a simple letter grade of A through F. Now, indeed, we want more uh A letter grades in our portfolio, right? Mom and dad didn't like the Fs, right? We also break out our seven unique component grades. Now, everything from a value, growth, momentum, and more. And then it helps show off a stock's unique strength and weaknesses. All right. Avant is in that elite tier of stocks with an A rating. And here, what's worth noting that is a worthy title uh because those stocks have historically beaten the S&P 500 by about 3 to1 over the past two decades. Now, let's look at the standout component grades. Starting with sentiment and momentum both in the top 25% of all stocks analyzed. Next up we have value in the top 21% of all stocks. Then the allimportant uh growth grade standing tall in the top 18% all stocks and the most uh the highest grade here today is top 12% showing for safety. All in all there is a lot to like in these shares. Now the one weak spot for Avon is that many of their end markets are cyclical. So any broad industrial slowdown would certainly pinch demand but right now there is no slowdown in sight just more growth and attractive value that is even more attractive after the recent dip from the highs. Now Avon is a nice low drawn away to open our stock list today. The next pick has a lot more horsepower and a lot more upside potential. So before I get to that next stock, here's something that might interest you just as much. I've put together a list of the three stocks I believe could double in the year ahead. I located all three using the same zen rings model featured in this video today. You can get that report for free by visiting wall streetzen.com or scan the QR code on your screen or clicking the link down in the description. Get your copy now. Okay, now let's shift into higher gear with tutorini with a symbol of TPC. This is one of the biggest heavy construction firms in the country. They build tunnels, bridges, transit systems, and mega projects that often take years and billions of dollars to finish. Their most recent quarter was an absolute blowout. Earnings nearly doubled what Wall Street was looking for. Even better, they have a $20 billion backlog of business already on hand. That is more than three years worth of projects on the books. That gives them great visibility into even more growth ahead. Even with all the growth in the shares, somehow they have faltered 15% from the high. This has pushed down their PEG ratio to a poultry 0.58. Right? shares could literally double from here and still be considered undervalued by typical standards. Once again, we have Wall Street analysts sleeping on these shares with just one covering analyst. Gladly, even when Wall Street is mostly MIA, we can still appreciate the merits of any stock thanks to that 115 factor review of the sun rings quantine scores in the top 4% of all stocks leading to that coveted A rating. The component grades help spill out the many attractive qualities of these shares and that story starts with the top 21% showing for financial strength. Sentiment comes in the top 16% of all stocks. This tells you the smart money is already building uh positions in these shares. Safety is nicely in the top 10% and the standout rate is for growth in the top 6% which typically foreshadows more growth and more earnings beats ahead. For a company converting a huge backlog into serious profits, then growth is exactly the grade you want leading the way. Now, note: Tutor is one of the top 20 stocks featured in my Zen Investor newsletter portfolio. Consider if it deserves a spot in your portfolio as well, especially after the recent juicy dip from the highs. Next up, we have a fantastic growth in value play in jazz pharmaceuticals with a symbol of, you guessed it, jazz. This is exactly the kind of stock I like to share on my free live training sessions every Monday. More on that [snorts] a little bit later. Right. Jazz is a profitable diversified biioharma company focused on sleep disorders, epilepsy, and a new fast growing cancer franchise. Now it's a profitable cash machine with real products and real cash flow. Now Jazz's oncology arm is the new growth driver. Right there their newer cancer therapies have been exploding into more usage and that is where a lot of the future growth is coming from. Right? This explains why Wall Street experts see earnings growing about 25% a year in the year ahead. More than double the pace of their peers. And just like the others in the video uh today uh investors have seen all this and yet somehow taken profits off the table. So, we get to jump in about 15 to 20% off the highs. Now, growth is nice, but growth plus value is much much nicer. So, it's good to know that Jazz carries that low PEG ratio like the other two stocks we talked about here. We're talking about 0.63. That is a shockingly low PE for a farmer company, especially a consistent grower like this one. The uh classic discounted cash flow model for valuing stocks shows the shares could rise over 100% to reach fair value from here. And this combination of healthy growth and deep value explains the ample Wall Street support that includes four buy and 13 strong buy recommendations. That's about as bullish as Wall Street gets on any stock. You already know what comes next and that is the sea level approval from the Zen ratings model where Jazz scores in the top 5% of all stocks. This again earns that elite A rating. Remember over the years A-rated stocks have beaten the S&P 500 by nearly 3 to one. The component grades helps highlight a broad array of strengths and that includes uh safety in the top 24% of all stocks, right? Pretty much what you would expect from a pharma stock like this one. And then their AI factor grade is in the top 17%. Now, we haven't talked about this one yet, but this is our usage of AI to find the most timely stocks. Both growth and momentum land in the top 15% of all stocks. Financial strength is a notch higher in the top 7%. Pretty much what you would expect from a cash machine uh company like Jazz. And the crown jewel is that top 1% showing for value. Now, that's not just a PEG ratio. That's just not discounted cash flow that is based upon 21 different measures, the points to value from just about every vantage point. Right? One risk here is that Jazz still leans heavily on just a handful of key drugs. So, any stumble in any one of them would have uh detrimental effects on the share price. Right now, with that blend of growth and value and Wall Street approval and Zen ratings profile, you understand why Jazz Pharmaceuticals just might be a healthy prescription for your portfolio. Now, our next pick is a bit of a Wall Street darling. And just one ask before we get there, and that's if you're enjoying this video, then take a second to subscribe and turn on the notification bell. Now, I publish data driven stock analysis like this every single week, and the bell makes sure that you actually get to see those videos coming up on your feed. All right, this brings us to our fourth stock today in a great turnaround story in darling ingredients with a symbol of D. Right, this is the world's largest recycler of uh animal byproducts and used cooking oil. They turn waste into valuable ingredients and through a big project uh joint venture, they also are making renewable diesel. Like I said, this stock is in the midst of a massive turnaround and that's why earnings are expected to ramp up sevenfold over last year. Now, of course, that growth is going to level off into the future, but does give you a sense of the magnitude of the turnaround underway as margins greatly improve. Now, growth is certainly a plus for stocks, but what you really want is growth above expectation. That's the best possible catalyst for shares. Indeed, that happened the past quarter with a massive 70% earning speed. Wall Street is taking notice leading to two buy and five strong by recommendation. This includes a street high target price about 45% above current levels. This comes from Manet Gupta of UBS. Now, that matters because Manet ranks in the top 5% of the entire street based on his actual stock picking prowess, meaning he knows a thing or two about picking good stocks. And it will be no shock to you that the Zen ratings loves this stock, too. Yet another A-rated company because in this case, they score in the top 2% of all stocks after that full 115 factor review. Yes, that means they are more appealing than 98% of the stocks analyzed. Now the component grades helps highlight all the areas of strength. We kick that off with a top 20% showing for safety. This is followed by top 19% for growth and top 14% for financial strength. Now I put those two together because these are the two most important grades to foreshadow more earnings beats ahead. Value is not too shabby in the top 12% of all stocks and the standout score is the top 8% showing for sentiment. This tells you the smart money crowd is already piling into shares. Now, on a stock that just pulled back, that is exactly what you want to see. The smart money buying the dip right alongside us. The main risk here is that Darling's fuel business rides on renewable diesel margins and those uh swing with governmental policies and commodity prices. But with the rules now set for a while and margins recovering, the wind is at their back. So, let's take advantage of share weakness to get on board. Now, next up, we had the biggest value play in the video today. But first up, I want to discuss our free live training sessions this coming Monday. This is when I share my uh updated market outlook and trading plan to outperform. It's also when I unveil my trade of the week based upon our proving Zen rings quant model and my greater than 40 years of investing experience. It's a free event, but you do need to register. You could do that now. Wall Streetzen.com/live or click the link down in the description down below or scan the QR code that's coming up on your screen. Now, just pause the video for a moment to sign up. I'll be patient and wait for you and I look forward to seeing you there on Monday. And hey, even if you can't join live this Monday, you should still sign up. That's because we send a replay to all registrants to watch whenever it's convenient. All right, my final stock just landed one of the largest public pension systems in America as a client. Is buying back its own shares handover fist and grades in the top 2% of the entire market for financial strength. Now, if that wasn't good enough, we get to buy it now at 25% below the highs. And that company is Progyny with a symbol PGNY. Uh, Progyny runs fertility and family uh, building benefits for big employers. Meaning that when a company wants to offer its people world-class fertility coverage, Progyny is exactly the com company they call. They just signed Kalpers, one of the largest pension systems in America. That's exactly the kind of bellweather client that gets the other big employers to follow. No doubt this emboldened management to start buying back shares hand over fist, right? Business is good. Like real good. This explains the hardy expectations for 30% earnings growth in the year ahead. Value also shows up in multiple places starting with the massive undervaluation found in the discounted cash flow model where shares could easily double in the year ahead. It also shines in the light of the PEG ratio a notch under one when 1.5 is the current market average. And yes, Wall Street analysts see the value too with price targets calling for up to 60% gains in the year ahead. Not to mention a new strong buy uh coverage from Wells Fargo calling for about 50% upside for shares, right? Plenty of value to be found. Of course, this is another A-rated stock. That's because they rank in the top 4% of the Zen Rings universe, pointing to a truly stellar investing profile. Now, let's go through that component grades hit parade value top 24% of all stock safety top 13% and growth top 12%. And the standout grade towering above the rest is the top 2% showing for financial strength. that points to operational excellence that shows up time and time again in their earnings reports in the past and likely to happen in the future. Now, one thing to watch that Progyny depends on landing and keeping big employer contracts, meaning the loss of any large customers would most certainly hurt shares gladly. The recent signing of Kalpers points to this trend being in their favor. So, here we have the deepest buy the dip opportunity in the video today. All while business is only looking brighter. That is why Wall Street is on board and that is why the Zen rings is impressed and that is why management is buying back shares by the truck full. Now it's time for you to consider backing up the truck yourself to get your Progyny shares. So there are the five stocks to consider buying while they're down. But typically quality by the dip opportunities like this don't last for long. So do your research soon and act. Thus a good time to remind you that the Zen rings are updated daily on wall streetzen.com. Be sure to look at the ratings before buying or selling any stock. And be sure to bookmark the site for all your future stock research needs. Now, I want to hear from you. Which of these five stocks is your favorite? And is there a beaten down name I didn't mention that you're buying right now? Share it all with our community down in the comments section below.